Loading insider details...
Latest Form 4 (Jun 15, 2026): Purchase of 21,700 CRVS shares, $250.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Corvus Pharmaceuticals, Inc. (CRVS) | Purchase | 21,700 | $250.2K |
| Oct 6, 2025 | Corvus Pharmaceuticals, Inc. (CRVS) | Grant/Award | 30,000 | n/a |